Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Diagnostic Approaches for the Diagnosis of Alzheimer's Disease: Technology Assessment and Clinical Effectiveness

NCT01450891 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT01450891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01450891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Diagnostic Approaches for the Diagnosis of Alzheimer's Disease: Technology Assessment and Clinical Effectiveness
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
July 31, 2013
Enrollment
304 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

memory disturbances, neurodegenerative diseases